The Effect of the HEP Approach in Infants With Down Syndrome
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Izgi Miray Demirbag
- Trial code
- NCT07163780
- Record updated
- 14 November 2025
- Original description
This study evaluates the effect of the HEP (Homeostasis-Enrichment-Plasticity) approach on motor and sensory development in infants with Down syndrome. Thirty-two infants will receive either HEP or traditional therapy over 12 sessions, and outcomes will be measured using standardized developmental tests.Read full original descriptionShow less
The Effectiveness of the HEP (Homeostasis-Enrichment-Plasticity) Approach in Infants With Down Syndrome
This study evaluates the effect of the HEP (Homeostasis-Enrichment-Plasticity) approach on motor and sensory development in infants with Down syndrome. Thirty-two infants will receive either HEP or traditional therapy over 12 sessions, and outcomes will be measured using standardized developmental tests.
Inclusion: Must be between 4 and 12 months old; Must have been diagnosed with Down Syndrome; Must not be at any neurological risk; Parent must agree to participate regularly in the study process.
Exclusion: History of intraventricular hemorrhage (Grade III or IV); Major vision or hearing impairment; History of febrile convulsion; Medical conditions (e.g., oxygen dependence) that prevent active participation in the study; Participation in other experimental rehabilitation studies.